Factors Influencing Adherence to Antiretroviral Therapy for HIV-Infected Female Inmates

Roberson, Donna W.; White, Becky L.; Fogel, Catherine Ingram

doi:10.1016/j.jana.2008.05.008

Cited by 38 publications

(79 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Small samples of incarcerated PLHIV have found corroborating reports of discrimination, maltreatment by staff and inmates, and breaches of confidentiality (e.g., status revealed by medication distribution practices; Derlega et al, 2010; Roberson, White, & Fogel, 2009). …”

Section: Discussionmentioning

confidence: 79%

“Inside These Fences Is Our Own Little World”: Prison-Based HIV Testing and HIV-Related Stigma Among Incarcerated Men and Women

Muessig¹,

Rosen

Farel

et al. 2016

AIDS Education and Prevention

Self Cite

View full text Add to dashboard Cite

Correctional facilities offer opportunities to provide comprehensive HIV services including education, testing, treatment, and coordination of post-release care. However, these services may be undermined by unaddressed HIV stigma. As part of a prison-based HIV testing study, we interviewed 76 incarcerated men and women from the North Carolina State prison system. The sample was 72% men, median age 31.5 years (range: 19 to 60). Thematic analysis revealed high levels of HIV-related fear and stigma, homophobia, incomplete HIV transmission knowledge, beliefs that HIV is highly contagious within prisons (“HIV miasma”), and the view of HIV testing as protective. Interviewees described social distancing behaviors and coping mechanisms they perceived to be protective, including knowing their HIV status and avoiding contact with others and shared objects. Interviewees endorsed universal testing, public HIV status disclosure, and segregation of HIV-positive inmates. Intensified education and counseling efforts are needed to ameliorate entrenched HIV-transmission fears and stigmatizing beliefs.

show abstract

Section: Discussionmentioning

confidence: 79%

“Inside These Fences Is Our Own Little World”: Prison-Based HIV Testing and HIV-Related Stigma Among Incarcerated Men and Women

Muessig¹,

Rosen

Farel

et al. 2016

AIDS Education and Prevention

Self Cite

View full text Add to dashboard Cite

show abstract

“…Second, the medications may be given at inconvenient times. Further, prisoners waiting in the DOT line may experience lack of confidentiality and feel stigmatized [8–10]. Finally, prisoners often do not trust the correctional officers and nurses staffing the DOT line to administer the correct antiretroviral medications [11].…”

Section: Introductionmentioning

confidence: 99%

Effect of Directly Observed Antiretroviral Therapy Compared to Self-Administered Antiretroviral Therapy on Adherence and Virological Outcomes among HIV-Infected Prisoners: A Randomized Controlled Pilot Study

et al. 2014

Self Cite

View full text Add to dashboard Cite

The effect of directly observed therapy (DOT) versus self-administered therapy (SAT) on antiretroviral (ART) adherence and virological outcomes in prison has never been assessed in a randomized, controlled trial. Prisoners were randomized to receive ART by DOT or SAT. The primary outcome was medication adherence [percent of ART doses measured by the medication event monitoring system (MEMS) and pill counts] at the end of 24 weeks. The changes in the plasma viral loads from baseline and proportion of participants virological suppressed (<400 copies/mL) at the end of 24 weeks were assessed. Sixty-six percent (90/136) of eligible prisoners declined participation. Participants in the DOT arm (n = 20) had higher viral loads than participants in the SAT (n = 23) arm (p = 0.23). Participants, with complete data at 24 weeks, were analyzed as randomized. There were no significant differences in median ART adherence between the DOT (n = 16, 99% MEMS [IQR 93.9, 100], 97.1 % pill count [IQR 95.1, 99.3]) and SAT (n = 21, 98.3 % MEMS [IQR 96.0, 100], 98.5 % pill count [95.8, 100]) arms (p = 0.82 MEMS, p = 0.40 Pill Count) at 24 weeks. Participants in the DOT arm had a greater reduction in viral load of approximately −1 log 10 copies/mL [IQR −1.75, −0.05] compared to −0.05 [IQR −0.45, 0.51] in the SAT arm (p value = 0.02) at 24 weeks. The proportion of participants achieving virological suppression in the DOT vs SAT arms was not statistically different at 24 weeks (53 % vs 32 %, p = 0.21). These findings suggest that DOT ART programs in prison settings may not offer any additional benefit on adherence than SAT programs.

show abstract

“…We know less, however, about why some HIV-infected men refuse HIV testing or how prisoners cope with an HIV diagnosis in jail/prison. There is also a lack of clear evidence about the best way to provide antiretroviral therapy (ART) to inmates (Springer and Altice, 2005; Roberson et al , 2009; Pontali, 2005), and adherence to ART frequently remains suboptimal despite tightly regulated administration of ART in custodial settings (Altice et al , 2001; Wohl et al , 2003). Most importantly, despite improving standards for correctional healthcare (Rold, 2008), prisoners too often view the provision of correctional health services as unjust, degrading, and dangerous (de Viggiani, 2007; Condon et al , 2007).…”

mentioning

confidence: 99%

Violence and the perceived risks of taking antiretroviral therapy in US jails and prisons

Culbert

2014

International Journal of Prisoner Health

View full text Add to dashboard Cite

Purpose About one in five men living with HIV in the USA passes through a correctional center annually. Jails and prisons are seen therefore as key intervention sites to promote HIV treatment as prevention. Almost no research, however, has examined inmates' perspectives on HIV treatment or their strategies for retaining access to antiretroviral therapy (ART) during incarceration. The purpose of this paper is to describe the results of an exploratory study examining men's perceptions of and experiences with HIV care and ART during incarceration. Design/methodology/approach Semi-structured, in-depth interviews were conducted with 42 HIV positive male and male-to-female transgendered persons recently released from male correctional centers in Illinois, USA. Findings Interpersonal violence, a lack of safety, and perceived threats to privacy were frequently cited barriers to one's willingness and ability to access and adhere to treatment. Over 60 percent of study participants reported missed doses or sustained treatment interruption (greater than two weeks) because of failure to disclose their HIV status, delayed prescribing, intermittent dosing and out-of-stock medications, confiscation of medications, and medication strikes. Research limitations/implications Substantial improvements in ART access and adherence are likely to follow organizational changes that make incarcerated men feel safer, facilitate HIV status disclosure, and better protect the confidentiality of inmates receiving ART. Originality/value This study identified novel causes of ART non-adherence among prisoners and provides first-hand information about how violence, stigma, and the pursuit of social support influence prisoner's decisions to disclose their HIV status or accept ART during incarceration.

show abstract

Factors Influencing Adherence to Antiretroviral Therapy for HIV-Infected Female Inmates

Cited by 38 publications

References 28 publications

“Inside These Fences Is Our Own Little World”: Prison-Based HIV Testing and HIV-Related Stigma Among Incarcerated Men and Women

“Inside These Fences Is Our Own Little World”: Prison-Based HIV Testing and HIV-Related Stigma Among Incarcerated Men and Women

Effect of Directly Observed Antiretroviral Therapy Compared to Self-Administered Antiretroviral Therapy on Adherence and Virological Outcomes among HIV-Infected Prisoners: A Randomized Controlled Pilot Study

Violence and the perceived risks of taking antiretroviral therapy in US jails and prisons

Contact Info

Product

Resources

About